Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx).
Publication
, Journal Article
Nicoll-Griffith, DA; Yergey, JA; Trimble, LA; Silva, JM; Li, C; Chauret, N; Gauthier, JY; Grimm, E; Léger, S; Roy, P; Thérien, M; Wang, Z ...
Published in: Bioorganic & medicinal chemistry letters
December 2000
Metabolites of the COX-2 inhibitor rofecoxib (MK-0966, Vioxx) were prepared by synthetic or biosynthetic methods. Metabolites include products of oxidation, glucuronidation, reduction and hydrolytic ring opening. Based on an in vitro whole blood assay, none of the known human metabolites of rofecoxib inhibits COX-1 nor contributes significantly to the inhibition of COX-2.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Bioorganic & medicinal chemistry letters
DOI
EISSN
1464-3405
ISSN
0960-894X
Publication Date
December 2000
Volume
10
Issue
23
Start / End Page
2683 / 2686
Related Subject Headings
- Sulfones
- Rats
- Prostaglandin-Endoperoxide Synthases
- Membrane Proteins
- Medicinal & Biomolecular Chemistry
- Lactones
- Isoenzymes
- Humans
- Drug Evaluation, Preclinical
- Cyclooxygenase Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Nicoll-Griffith, D. A., Yergey, J. A., Trimble, L. A., Silva, J. M., Li, C., Chauret, N., … Riendeau, D. (2000). Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx). Bioorganic & Medicinal Chemistry Letters, 10(23), 2683–2686. https://doi.org/10.1016/s0960-894x(00)00538-2
Nicoll-Griffith, D. A., J. A. Yergey, L. A. Trimble, J. M. Silva, C. Li, N. Chauret, J. Y. Gauthier, et al. “Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx).” Bioorganic & Medicinal Chemistry Letters 10, no. 23 (December 2000): 2683–86. https://doi.org/10.1016/s0960-894x(00)00538-2.
Nicoll-Griffith DA, Yergey JA, Trimble LA, Silva JM, Li C, Chauret N, et al. Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx). Bioorganic & medicinal chemistry letters. 2000 Dec;10(23):2683–6.
Nicoll-Griffith, D. A., et al. “Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx).” Bioorganic & Medicinal Chemistry Letters, vol. 10, no. 23, Dec. 2000, pp. 2683–86. Epmc, doi:10.1016/s0960-894x(00)00538-2.
Nicoll-Griffith DA, Yergey JA, Trimble LA, Silva JM, Li C, Chauret N, Gauthier JY, Grimm E, Léger S, Roy P, Thérien M, Wang Z, Prasit P, Zamboni R, Young RN, Brideau C, Chan CC, Mancini J, Riendeau D. Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx). Bioorganic & medicinal chemistry letters. 2000 Dec;10(23):2683–2686.
Published In
Bioorganic & medicinal chemistry letters
DOI
EISSN
1464-3405
ISSN
0960-894X
Publication Date
December 2000
Volume
10
Issue
23
Start / End Page
2683 / 2686
Related Subject Headings
- Sulfones
- Rats
- Prostaglandin-Endoperoxide Synthases
- Membrane Proteins
- Medicinal & Biomolecular Chemistry
- Lactones
- Isoenzymes
- Humans
- Drug Evaluation, Preclinical
- Cyclooxygenase Inhibitors